Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
Key Points
The aim is to evaluate the long-term outcomes of allogeneic hematopoietic cell transplantation in patients with T-cell prolymphocytic leukemia.
Conducted on behalf of the Chronic Malignancies Working Party of the EBMT.
Included various cohorts of patients undergoing allogeneic transplantation.
Assessed long-term survival and disease-free survival rates.
Significant improvement in survival rates post-transplant compared to historical controls.
Increased rates of complete remission observed in treated patients.
Reduction in recurrence rates following allogeneic transplantation.
Abstract
Not available.
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT | Synapse
Cite This Study
Drozd-Sokolowska et al. (Thu,) studied this question.